-

SHAREHOLDER NEWS: Johnson Fistel Investigates Proposed Sale of Icosavax; Is the Deal in the Best Interest of Shareholders?

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Icosavax, Inc. (NASDAQ: ICVX) breached their fiduciary duties in connection with the proposed sale of the Company to AstraZeneca.

You can click or copy and paste the following link to join this investigation:

https://www.johnsonfistel.com/investigations/Icosavax-co

On November 30, 2023, Icosavax announced that it had entered a deal to merge with AstraZeneca. Under the terms of the deal, Icosavax shareholders will receive $15.00 per share in cash at closing, plus a non-tradable contingent value right to receive up to $5.00 in cash, payable upon achievement of specified regulatory and net sales milestones.

Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given a one Wall Street analyst has a $30.00 price target on the stock. If you are a shareholder of Icosavax and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:

Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, and Colorado. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com.

Johnson Fistel, LLP is a shareholder rights law firm representing individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information, visit their website http://www.johnsonfistel.com.

Attorney advertising.

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices.

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

Industry:

Johnson Fistel, LLP

NASDAQ:ICVX
Release Versions
English

Contacts

Johnson Fistel, LLP
501 W. Broadway, Suite 800, San Diego, CA 92101
James Baker, Investor Relations or Frank J. Johnson, Esq., (619) 814-4471
jimb@johnsonfistel.com or fjohnson@johnsonfistel.com

More News From Johnson Fistel, LLP

Beta Bionics Investors Suffer Significant Losses After Company Reports Slower New Patient Start Growth; Contact Johnson Fistel

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating whether Beta Bionics, Inc. (NASDAQ: BBNX) or certain of its executive officers violated federal securities laws. The investigation focuses on investors’ losses and whether they may be recovered under federal securities laws.What if I purchased Beta Bionics securities?If you purchased Beta Bionics securities and suffered losses on your investment, join our investigation now: Click Here to Join the Investigation.Or for more informat...

Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential claims on behalf of Simulations Plus, Inc. (NASDAQ: SLP) investors concerning whether the Company or certain of its executive officers violated federal securities laws.The Simulations Plus investigation focuses on investor losses following the Company’s revised fiscal 2025 revenue outlook, reported impairment charge, auditor dismissal, and disclosures concerning segment reporting, reporting-unit determinations, and inter...

Johnson Fistel Investigates Potential Board Fiduciary Duty Breaches at Lee Enterprises, Inc.

SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duty by the Board of Directors of Lee Enterprises, Inc. (NASDAQ: LEE). If you own Lee Enterprises shares, please consider joining our investigation. To participate or learn more, you can click or copy and paste the following link: https://www.johnsonfistel.com/investigations/lee-enterprises-inc/ Shareholders seeking more information may also contact lead analyst Jim Baker (jimb@johns...
Back to Newsroom